JDRF-funded researchers have begun enrolling adult patients with type 1 diabetes in the REMOVAL study, to test whether m…

JDRF-funded researchers have begun enrolling adult patients with type 1 diabetes in the REMOVAL study, to test whether m…
A study released by Novo Nordisk at the International Diabetes Federation (IDF) 21st World Diabetes Congress in Dubai ha…
Sanofi announced positive results from the Gel Duo 1 study of it's investigational GLP-1 agonist, Lyxumia (lixisenatide)…
Data from the A1chieve® study, evaluating adverse events and effectiveness of Novo Nordisk insulins (NovoMix 30, Levemir…
JDRF has partnered with over 700 online stores to raise money for diabetes research. To participate in this fundraiser …
Researchers at Joslin Diabetes Center have determined key differences between Type 1 and Type 2 diabetes in the Asian Am…
Eli Lilly has announced it is conducting the first major international, prospective observational study designed to unde…
The U.S. Food and Drug Administration (FDA) issued draft guidance designed to help investigators and manufacturers as th…
The European Commission has approved Bristol-Myers Squibb Company and AstraZeneca's ONGLYZA (saxagliptin) for use as a c…
Exercising with diabetes is complicated and although it's generally a good thing, it can make diabetes management more d…